Submission Details
| 510(k) Number | K234028 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2023 |
| Decision Date | February 15, 2024 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K234028 is an FDA 510(k) clearance for the COPAL? exchange G hip spacer; COPAL? G+V, a Prosthesis, Hip, Hemi-, Femoral, Metal (Class II — Special Controls, product code KWL), submitted by Heraeus Medical GmbH (Wehrheim, DE). The FDA issued a Cleared decision on February 15, 2024, 57 days after receiving the submission on December 20, 2023. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3360.
| 510(k) Number | K234028 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 20, 2023 |
| Decision Date | February 15, 2024 |
| Days to Decision | 57 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | KWL — Prosthesis, Hip, Hemi-, Femoral, Metal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3360 |